pentobarbital will decrease the extent or outcome of glecaprevir/pibrentasvir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.Sodium valproate and valproic acid seem to lower barbiturate metabolism; therefore, barbiturate blood ranges needs to be monitored and ideal dosage changes built as indicated.pentobarbital will lessen the extent or